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Itaconic acid, a C5-dicarboxylic acid, is a potential biobased building block for
the polymer industry. It is obtained from the citric acid cycle by decarboxylation
of cis-aconitic acid. This reaction is catalyzed by CadA in the native itaconic acid
producer Aspergillus terreus. Recently, another enzyme encoded by the mammalian
immunoresponsive gene 1 (irg1), was found to decarboxylate cis-aconitate to itaconate
in vitro. We show that heterologous expression of irg1 enabled itaconate production in
Escherichia coli with production titres up to 560 mg/L.
Keywords: itaconic acid, Escherichia coli, metabolic engineering, cis-aconitate decarboxylase,
immunoresponsive gene 1, codon optimization, codon harmonization
Introduction
Itaconic acid is a biotechnologically produced monomer, which can be used as a precursor for
many industrially important chemicals such as acrylic plastics, acrylate latices, and absorbents.
After being listed as a top 12 value-added biobased chemical compound (Werpy and Petersen,
2004), microbial production of itaconic acid has been of special interest for a decade.
Studies on the biotechnological production of itaconic acid have either focused on strain
breeding of natural itaconic acid producers (mainly Aspergillus terreus), or on the heterologous
expression of cadA, the key gene encoding cis-aconitate decarboxylase in A. terreus in other host
organisms (Klement and Büchs, 2013). The economics of itaconic acid production with A. terreus
are negatively inﬂuenced by the slow growth of the organism and the sensitivity of the ﬁlamentous
pellets to hydro-mechanical stress, which inhibits mass transfer and consequently oxygen supply to
the cells. Consequently, the production costs are still too high for industrial application of itaconic
acid as a starting material (Steiger et al., 2013). Development of alternative hosts for itaconate
production could overcome these problems. Escherichia coli may be a suitable candidate host as
it grows rapidly under both aerobic and anaerobic conditions and has well-established protocols
for genetic modiﬁcation.
The mammalian immunoresponsive gene 1 (irg1) was recently found to have in vitro cis-
aconitate decarboxylase activity, although it has only 24% amino acid sequence identity with CadA
from A. terreus (Michelucci et al., 2013). However, both Irg1 and CadA share high identity with
MmgE/PrpD family of proteins (Lohkamp et al., 2006; Kanamasa et al., 2008). Irg1 from Mus
musculus was highly active in mammalian macrophages during inﬂammation and was linked to
having a role in immune defense by catalyzing itaconic acid production (Michelucci et al., 2013),
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making the enzyme also an interesting candidate for
biotechnological itaconic acid production. E. coli has been
successfully used as a host for itaconic acid production by
expressing cadA (Li et al., 2011; Okamoto et al., 2014; Vuoristo
et al., 2015) and is therefore an interesting candidate to test
whether irg1 can be used for microbial itaconate production.
In earlier studies inclusion body formation was observed in
E. coli that was overexpressing cadA from A. terreus (Vuoristo
et al., 2015). Expression of heterologous genes in E. coli often
causes problems such as protein miss-folding and inclusion
body formation, which lead to synthesis of inactive enzymes.
In recent years many tools, such as codon harmonization,
have been developed to optimize a codon usage to its best.
Compared to codon optimization, which substitutes codons
by the most frequently used codons of the expression host
(Makrides, 1996), codon harmonization selects the codons with
usage frequencies in the expression host that most closely match
the usage frequencies in the native host (Angov et al., 2008). This
harmonization leads to better control of the translation speed
and may prevent miss-folding of the nascent polypeptide (Angov
et al., 2011).
In this study, we heterologously expressed irg1 in E. coli. The
proposed itaconate pathway in E. coli is shown in Figure 1.
The eﬀect of codon-harmonization on itaconate production and
enzyme activity was determined. We showed that expression of
mammalian immunoresponsive gene 1 (irg1) results in itaconate
production in E. coli.
Materials and Methods
Bacterial Strains and Plasmids
The bacterial strains and plasmids used in this study are listed in
Table 1.
Codon-Optimization and Codon-Harmonization
Codon-optimization was done according to the algorithm of
OptimumGeneTM (GenScript). The codon usage of cadA from
FIGURE 1 | Itaconate production pathway in Escherichia coli.
The bold arrows indicate the introduced pathway consisting of
genes encoding citrate synthase (gltA) and aconitase (acnA) from
Corynebacterium glutamicum and cis-aconitate decarboxylase (cadA)
from Aspergillus terreus or immunoresponsive gene 1 (irg1) from
Mus musculus. The dotted lines indicate that phosphate
acetyltransferase (pta) and lactate dehydrogenase (ldhA) were
deleted.
TABLE 1 | Escherichia coli strains and plasmids used in this study.
Strains and plasmids Characteristics Reference
Strains
BW25113 (DE3) BW25113 DE3 T7 RNA polymerase Vuoristo et al. (2015)
BW25113 (DE3) pta–ldhA BW25113 pta–ldhA DE3 T7 RNA polymerase Vuoristo et al. (2015)
Plasmids
pKV-GACopt pACYCDuet-1 derivative (Novagen), codon-optimized gltA and acnA from Corynebacterium
glutamicum, codon-optimized cadA from Aspergillus terreus
Vuoristo et al. (2015)
pKV-GA pACYCDuet-1 derivative, codon-optimized gltA and acnA from C. glutamicum This study
pKV-GAChar pACYCDuet-1 derivative (Novagen), gltA and acnA from C. glutamicum, codon-harmonized cadA
from A. terreus
This study
pKV-GAIopt pACYCDuet-1 derivative (Novagen), codon-optimized irg1 from M. Musculus, acnA, and gltA from
C. glutamicum
This study
pKV-GAIhar pACYCDuet-1 derivative (Novagen), codon-harmonized irg1 from C. glutamicum, codon- optimized
acnA, and gltA from C. glutamicum
This study
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A. terreus and irg1 from M. musculus was harmonized to that
of E. coli. For this, the codon usage frequency per codon was
determined for the native organism and for the host by using the
graphical codon usage analyser tool (Fuhrmann et al., 2004). The
codons used in the harmonized genes are the E. coli codons that
mimicked the codon usage frequencies in the native organism
the best. Genes were synthesized by GenScript and nucleotide
sequences were deposited to NCBI BankIt (accession numbers:
cadA optimized KM464677, cadA harmonized KT273316, irg1
optimized KT273318, and irg1 harmonized KT273317).
Construction of pACYCDuet-1 Expression Vectors
All strains and plasmids used in this work are given in Table 1.
All optimized and harmonized cadA and irg1 sequences were
expressed by using the T7 promotor in MCS1 of pACYCDuet-
1. The control vector pKV-GA was derived from pKV-GACopt
by cloning the acnA and gltA-containing part of pKV-GACopt
in MCS2 of pACYCDuet-1. In addition, harmonized cadA,
optimized irg1 or harmonized irg1 sequences were cloned in
MCS1 of pKV-GA resulting in pKV-GAChar, pKV-GAIopt and
pKV-GAIhar, respectively. Constructed plasmids were veriﬁed by
sequencing.
Culture Media
For plasmid construction, E. coli strains were cultured at 37◦C
on lysogeny broth (LB) agar plates or in LB liquid medium
and agitation rates of 200 rpm. Medium and plates were
supplemented with chloramphenicol (35 μg/mL).
The other cultivations were done in M9 minimal medium
(MM), which contained per 1 L: 200 mL 5 × M9 Minimal Salts
(BD Difco) supplemented with 50 mM of glucose, 2 mM of
MgSO4, 0.1 mM of CaCl2, 15 mg of thiamine, and 0.30 mg of
selenite and US∗ trace elements (Panke et al., 1999). Medium
was buﬀered with 0.1 M 3-(N-morpholino) propanesulfonic
acid (MOPS) and the pH was adjusted to 6.9 with NaOH.
Induction of gene expression was started by the addition of
0.5 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG) when
the optical density at 600 nm (OD600) of the culture reached
approximately 0.4.
SDS-PAGE
For SDS-PAGE, E. coli BW25113 (DE3) pta–ldhA containing
either pKV-GA, pKV-GACopt, pKV-GAChar, pKV-GAIopt, or
pKV-GAIhar was cultivated for 16 h at 37◦C and 200 rpm in 2 mL
MM. Subsequently, the overnight cultures were transferred into
20 mL of fresh MM and incubated at 25◦C and 200 rpm. When
the cultures reached an OD600 of approximately 0.4, they were
induced with 0.5 mM IPTG and incubated overnight at 25◦C and
200 rpm.
Sixteen-milliliter of the cultures were used to make cell free
extracts (CFE) according to the Y-PER Yeast Protein Extraction
Reagent kit instructions (Thermo Scientiﬁc). Four-milliliter of
the cultures were harvested by centrifugation (2 min, 14000 rpm),
resuspended in a small volume of water, and loaded on pre-casted
Criterion XT SDS-PAGE gels (Bio-Rad) together with the CFE’s
according to manufacturer’s instructions (CriterionTM Cell, Bio-
Rad). The proteins were stained by Bio-Safe Coomassie staining
(Bio-Rad). Protein sizes were determined by using Precision Plus
ProteinTM All Blue Standards ladder (Bio-Rad).
Bioreactor Cultures
Escherichia coli BW25113 (DE3) pta–ldhA containing either
pKV-GA, pKV-GACopt, pKV-GAChar, pKV-GAIopt, or pKV-
GAIhar was cultivated at 25◦C in 0.5 L Mini Bioreactors,
connected to myControl controller units (Applikon, The
Netherlands) with a working volume of 400 ml. The pH was
maintained at 6.9 by the automated addition of 2 M NaOH.
Bioreactors were inoculated with 5% (v/v) of a pre-culture that
was grown at 37◦C in a 250 mL Erlenmeyer ﬂasks with 50 mL of
MM at 250 rpm for 24 h. The bioreactor cultures were stirred at
500 rpm and sparged with air at 200 mL/min for 8 h, after which
the stirring speed was increased to 1200 rpm and the sparging
rate was increased to at 400 mL/min. Samples of 2 mL were
regularly taken to determine the OD600 of the cultures and the
concentrations of substrate and products.
cis-Aconitate Decarboxylase Assay
For enzymatic assays, 30 mL of bioreactor culture was harvested
by centrifugation (5 min, 7745× g) after 17 h of cultivation in the
presence of IPTG. CFE were made according to the Y-PER Yeast
Protein Extraction Reagent kit instructions (Thermo Scientiﬁc).
Protein concentrations were determined by using the Total
Protein Kit, Micro Lowry, Onishi and Barr Modiﬁcation (Sigma–
Aldrich).
The activity of CadA and Irg1 was measured with cis- and
trans-aconitate according to Vuoristo et al. (2015). Besides, the
Irg1 activity was measured by using a method adapted from
Michelucci et al. (2013) with the following modiﬁcations: CFE’s
were incubated with 200 mM of cis-aconitate in 25 mM HEPES
buﬀer (pH 7.1) supplied with proteinase inhibitor (cOmplete
Protease Inhibitor Cocktail Tablets, Roche) for 50 min at
30◦C.
For whole cell assays, 20 mL of bioreactor culture was
harvested by centrifugation (5 min, 7745 × g) after 17 h of
cultivation in the presence of IPTG. Cells were washed with M9
salts in 100 mM MOPS (pH 7.1) and resuspended in 10 ml of
the same medium. Twenty-millimeter of substrate (cis- or trans-
aconitate) was added to 2mL of the cell suspension and incubated
at 30◦C and 100 rpm. 1 M HCl was added to terminate the
reaction, after which the supernatants were analyzed for itaconate
formation by HPLC.
Analytical Methods
The cell density was determined bymeasuring the OD600 by using
a DR6000 spectrophotometer (Hach Lange).
The concentrations of glucose and organic acids were
determined by using a Perkin Elmer (200 series) HPLC equipped
with an RI detector (PerkinElmer, Flexar) for measuring glucose
and an UV detector (PerkinElmer, Flexar UV/V, at 210 nm)
for citric acid, itaconic acid, cis- and trans-aconitic acid. The
samples were separated on a Micro Guard Cation H pre-column
(30 mm × 4.6 mm, Biorad) and an Aminex HPX-87H column
(300 mm × 7.8 mm, Biorad) at 35◦C, using 0.5 mL/min of 5 mM
H2SO4 as eluent.
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Results
Heterologous Expression of cadA and irg1
Optimized and harmonized gene sequences of cadA from
A. terreus and irg1 from M. musculus were expressed in E. coli
BW25113 (DE3) pta–ldhA together with gltA and acnA from
Corynebacterium glutamicum. The strains were cultivated in
shake ﬂasks on MM at 25◦C and induced with IPTG. Samples
of culture pellets and CFE of the cultures were analyzed by SDS-
PAGE. A protein band of around 53 kDa appeared on the SDS-
PAGE gels, which is the expected size of the proteins encoded by
cadA and irg1 (ﬁgure provided in the Supplementary Material).
The samples of culture pellets gave very thick protein bands at
the expected sizes, while much thinner bands were obtained with
CFE’s, indicating that CadA and Irg1 were mostly in the form
of inclusion bodies. No large diﬀerences were observed between
the amounts of CadA or Irg1 on the gels after expression of the
optimized and harmonized genes. The proteins encoded by gltA
and acnA have sizes of 49 kDA and 114 kDA.
Enzymatic Assays
cis-Aconitate decarboxylase activity was measured in CFE’s of
bioreactor cultures after 17 h of cultivation at 25◦C in the
presence of IPTG. The speciﬁc conversion rate of cis-aconitate to
itaconate in CFE of E. coli BW25113 (DE3) pta–ldhA with
pKV-GAChar was 1.39 μmol itaconate/min/mg protein, which
was 1.7 times higher than with pKV-GACopt. CadA activities
were higher than those previously obtained with cells cultivated
at 30 and 37◦C (Vuoristo et al., 2015), indicating that inclusion
body formation is more suppressed at 25◦C. Itaconate formation
was not detected with CFE’s of cultures with pKV-GA, pKV-
GAIopt, or pKV-GAIhar. Instead, cis-aconitate was converted to
citrate, which is likely caused by the activity of aconitase in the
CFE. Itaconate formation was also absent in cell lysates of pKV-
GAIopt and pKV-GAIhar that were not centrifuged, indicating
that Irg1 activity is not present in the membrane fraction of
the cells. Trans-aconitate was not converted by any of the
CFE’s.
Irg1 activities were also determined according to Michelucci
et al. (2013). Again, no itaconate formation was detected under
these conditions (results not shown). The absence of conversion
of cis-aconitate to itaconate in CFE of E. coli BW25113 (DE3)
pta–ldhA expressing irg1 suggests that Irg1 was inactivated in
the period between the harvest of the cells and the measurements.
Whole Cells Assays
Conversion of cis-aconitate to itaconate by cells of E. coli
BW25113 (DE3) pta–ldhA containing pKV-GA, pKV-
GACopt, pKV-GAChar, pKV-GAIopt, and pKV-GAIhar was
measured by incubating cells in the presence of 20 mM of cis-
or trans-aconitate and measuring the formation of itaconate
in the supernatant. Whole cells containing pKV-GACopt, pKV-
GAChar, pKV-GAIopt, and pKV-GAIhar converted cis-aconitate to
itaconate. Trans-aconitate was not converted (data not shown).
The highest conversion rate was observed with pKV-GAIhar
(1.10 μmol itaconate/min/mg cells, Figure 2), which was much
higher than with pKV-GAIopt (0.19 μmol itaconate/min/mg
FIGURE 2 | Conversion of cis-aconitate to itaconate (µmol
itaconate/min/mg cells) by whole cells of E. coli BW25113 (DE3)
pta–ldhA containing pKV-GA, pKV-GACopt, pKV-GAChar,
pKV-GAIopt, and pKV-GAIhar. The average values of duplicate
measurements are given.
cells). The conversion rates of pKV-GACopt and pKV-GAChar
were (0.41 and 0.31 μmol itaconate/min/mg cells).
Bioreactor Cultures
The eﬀect of expression of cadA and irg1 on itaconate
production was studied in E. coli BW25113 (DE3) pta–ldhA,
in which the genes encoding phosphate acetyltransferase and
lactate dehydrogenase were disrupted. gltA and acnA from
C. glutamicum were expressed together with the target genes.
The strains were cultivated under aerobic conditions in pH-
controlled bioreactors on MM at 25◦C. Itaconate was produced
in all cultures, except in the control pKV-GA (Figure 3). Strains
containing the harmonized genes (pKV-GAChar and pKV-
GAIhar) produced slightly less itaconate than those containing
the optimized genes (pKV-GACopt and pKV-GAIopt). The latter
strains produced 5.5 and 4.3 mM, respectively.
Discussion
Since the identiﬁcation of the gene encoding cis-aconitate
decarboxylase (cadA) in A. terreus (Kanamasa et al., 2008),
there has been a growing interest to produce itaconic acid in
recombinant hosts such as E. coli (Liao and Chang, 2010; Li
et al., 2011). Metabolic engineering strategies to increase the ﬂux
through the citric acid cycle and to reduce by-product formation
have signiﬁcantly increased the itaconate titres obtained with
E. coli (Okamoto et al., 2014; Vuoristo et al., 2015), but they
are still far below those obtained with A. terreus (Hevekerl et al.,
2014). One of the possible bottlenecks in E. coli is the low activity
of the heterologous CadA.
Although E. coli is a widely used cell-factory for the production
of proteins and chemicals, problems such as inclusion body
formation and low enzyme activity are often associated with
heterologous production of proteins. For instance, low enzyme
activities may occur when the frequency of synonymous codons
in foreign coding DNA signiﬁcantly diﬀers from that of the
host (Rosano and Ceccarelli, 2014). Harmonization of the codon
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FIGURE 3 | Itaconate production in bioreactor cultures containing E. coli BW25113 (DE3) pta–ldhA with pKV-GA, pKV-GACopt, or pKV-GAChar
(A) or pKV-GA, pKV-GAIopt, or pKV-GAIhar (B). The average values and SD of duplicate cultures are given.
usage frequencies of the target gene with those of the expression
host can increase their expression (Angov et al., 2008; Van Zyl
et al., 2014). We compared expression of codon optimized and
harmonized sequences of cadA and irg1 by determining enzyme
activities and performance in bioreactor cultures. The speciﬁc
enzymatic activity with harmonized cadA was 1.7 times higher
than with optimized cadA. In contrast, the speciﬁc conversion
rate of cis-aconitate by whole cells containing pKV-GAChar was
only 75% of the rate observed with pKV-GACopt, and the titre
obtained in bioreactor cultures with pKV-GAChar was 74% of
that obtained with pKV-GACopt. This suggests that other factors,
like itaconate export, by-product formation, or levels of other
enzymes involved in itaconate biosynthesis have a larger eﬀect on
itaconate production than the activity of CadA.
Okamoto et al. (2014) measured increased intracellular
itaconate concentrations in their production strains and
suggested that extracellular secretion of itaconate in E. coli
limits the production. Itaconate transport has been studied
in Aspergillus species and a few putative candidates have
been characterized (Li et al., 2011). Expression of A. terreus
mitochondrial transporter mttA and plasma membrane
transporter mfsA were beneﬁcial to production in A. niger
(Li et al., 2013; van der Straat et al., 2014). So far, itaconate
transporters have not been identiﬁed in E. coli, and the transport
mechanism is unknown, which makes them obvious research
targets for the future.
Besides CadA, alternative cis-aconitate decarboxylases can
facilitate itaconate production. Recently, the gene product of
immunoresponse gene 1 (irg1) from M. musculus was shown
to catalyze the decarboxylation of cis-aconitate to itaconic acid
in vitro (Michelucci et al., 2013). We were unable to detect
any cis-aconitate decarboxylase activity in CFE’s of E. coli
cultures expressing irg1, although the cultures were producing
itaconate. This indicates that the enzyme was inactivated during
preparation of CFE’s. Whole cells of pKV-GAIhar converted cis-
aconitate nearly 5.5 times as fast as pKV-GAIopt. Still, the titre of
pKV-GAIhar was less than the titre of pKV-GAIopt.
We showed for the ﬁrst time that introduction of this
mammalian enzyme also results in itaconate production in E. coli
with titres up to 560mg/L. The titres are similar to those obtained
with cadA-expressing E. coli strains (700 mg/L), although the
protein sequences are only 24% identical.
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Conclusion
We have successfully expressed a mammalian cis-aconitate
decarboxylase encoded by irg1 fromM. musculus in E. coli. Titres
up to 560 mg/L of itaconate were obtained with irg1, which
are comparable to those obtained with cadA from A. terreus
(700 mg/L). Codon harmonization increased the activity CadA
in CFE, but this did not result in higher itaconate production
in bioreactor cultures, suggesting that other factors are limiting.
Besides irg1 from mouse, also other immunoresponse genes
are known. Many of them may possess CadA activity and
it should be investigated which ones are best for itaconate
production.
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